特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
640324

止血剤:創傷ケア市場の分析・予測モデル

Hemostats - Wound Care Market Analysis and Forecast Model

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
止血剤:創傷ケア市場の分析・予測モデル
出版日: 2017年08月31日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の主要39カ国の止血剤の市場を調査し、市場および製品の概要、主な産業動向、インストールベース、新規販売数、平均販売価格などの各種データとその推移、製品の年間収益の推移と予測、競合環境と企業シェア、アナリストによる各種分析などをまとめています。

主な調査内容

  • 現在市販されている製品・競合動向
  • 主な産業動向のレビュー
  • 年間収益の推移・予測:各種区分別
    • トロンビン
    • 併用止血剤
    • 酸化再生セルロース
    • 多糖止血剤
    • ゼラチン
    • コラーゲン
  • 各種詳細データ
    • インストールベース
    • 新規販売数
    • 平均販売価格、など
  • 企業シェア
  • アナリストによる分析

本書のメリット

  • パイプライン製品・技術をレビューし、ロバストパイプラインを持つ企業を特定することで、インライセンシング&アウトライセンシング戦略の構築・設計が可能に
  • 製品市場を形成・推進する動向を理解することで、事業戦略の構築が可能に
  • 主要動向、革新的製品&技術、影響力を持つ企業などについて理解を深めることで、収益の推進が可能に
  • 競合環境を理解し、市場リーダーのシェアを分析することで、有効な販売・マーケティング戦略の構築が可能に
  • 競合上優位に立つため、潜在力のある製品ポートフォリオを持つ新興企業を特定し、有効な対抗戦略を練ることが可能に
  • 世界・国別のデバイス売上の推移・予測の追跡が可能に
  • 統合・投資・戦略的提携の最大の機会を示す市場の区分・カテゴリーを特定することで、販売・マーケティングの取り組みを活動の体系化が可能に
目次
Product Code: GDME089MM

Hemostats - Wound Care Market Analysis and Forecast Model is built to better visualize quantitative market trends of Hemostats within the Wound Care Management market.

The color-coded and fully-sourced models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share analysis. Moreover, analyst comments with qualitative insight offer context for quantitative data.

Hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective. They are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon.

The Hemostats Market is segmented into Thrombin Based Hemostats, Combination Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Polysaccharide Based Hemostats, Gelatin Based Hemostats and Collagen Based Hemostats.

Each of the covered 39 country's market models are further segmented to provide granularity and pertinent data for respective market.

Key Inclusions of these market models are -

  • Currently marketed Hemostats and evolving competitive landscape.
  • Insightful review of the key industry trends.
  • Annualized total Hemostats market revenue by segment and market outlooks from 2005-2024.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Robust methodologies and sources enable these market models to provide extensive and accurate overviews of markets. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.

Built with help of thousands of interviews with demand side participants, majority of them are physicians, surgeons, and specialists within their therapeutic areas. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, Chile

Scope:

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have a deep understanding of the marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy:

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Hemostats market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hemostats market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Hemostats market from 2005-2024
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.